Epstein-Barr virus in head and neck cancer assessed by quantitative polymerase chain reaction

David Goldenberg, Nicole E. Benoit, Shahnaz Begum, William H. Westra, Yoram Cohen, Wayne M. Koch, David Sidransky, Joseph A. Califano

Research output: Contribution to journalArticlepeer-review

38 Scopus citations


Objectives/Hypothesis: Epstein-Barr virus (EBV) has classically been associated with nasopharyngeal carcinoma and Burkitt's lymphoma. Recently, multiple studies have been published linking EBV with oral squamous cell carcinoma and, to a lesser extent, hypopharyngeal and laryngeal tumors. Using a sensitive method of detection, the authors sought to analyze the presence and quantity of EBV DNA in a large cohort of head and neck cancers. Study Design: Retrospective cohort study. Methods: Three hundred head and neck cancer samples exclusive of nasopharyngeal carcinoma were examined for the presence of EBV using quantitative polymerase chain reaction. Eighty-four tumor samples from the larynx, 30 from the hypopharynx, 73 from the oropharynx, and 113 from the oral cavity were analyzed for EBV quantity, which was expressed as the number of viral copies per cell genome. Representative samples, which contained the highest EBV DNA levels, were examined using in situ hybridization. Results were correlated with tumor grade and site and tobacco and alcohol exposure. Results: Three of 300 (1%) tumor samples were overtly positive for EBV DNA (defined as >0.1 copies of viral DNA/cell genome). Five of 300 (2%) tumor samples showed low levels (defined as >0.01 and <0.1 copies of viral DNA/cell genome), and 68 of 300 tumor samples (23%) showed trace levels (defined as <0.01 copies of viral DNA/cell genome) of EBV DNA. No correlation was found between EBV positivity and tobacco exposure, alcohol exposure, or tumor grade. Conclusion: In the overwhelming majority of head and neck cancers in this North American cohort, EBV did not appear to contribute to growth of a dominant clonal population with integrated EBV genome and was unlikely to be a genetic etiological agent in tumor development. The low quantities of EBV detected in a minority of head and neck cancers may be related to the presence of EBV genome in rare lymphoid or epithelial cells adjacent to the primary head and neck cancer.

Original languageEnglish
Pages (from-to)1027-1031
Number of pages5
Issue number6
StatePublished - 1 Jun 2004
Externally publishedYes


  • Epstein-Barr virus
  • Head and neck squamous cell carcinoma
  • Molecular analysis
  • Real-time polymerase chain reaction
  • Viral oncogenesis

ASJC Scopus subject areas

  • Otorhinolaryngology


Dive into the research topics of 'Epstein-Barr virus in head and neck cancer assessed by quantitative polymerase chain reaction'. Together they form a unique fingerprint.

Cite this